Market LIVE
Published markets; coverage varies by country
Product profile · United States

LYMEPAK

 ·  Patent Litigation & Settlement History ↓

IngredientDOXYCYCLINE HYCLATE
Application typeNDA
Application209844
Product001
Dosage formTABLET
RouteORAL
StrengthEQ 100MG BASE
Approval date2018-06-15
Marketing statusDiscontinued
Status event—
ApplicantCHARTWELL PHARMA
Product source

Current GenericRadar decision

Year—
SelectionDISCONTINUED
ReviewFINAL
Anchor typeDISCONTINUATION
Anchor date—
Patent anchor—
Exclusivity anchor—
Protection date—
First Final ANDA—
Status event—

Current FDA Orange Book lists the exact product as discontinued. The actual discontinuation date is not established and is kept null; approval and observation dates are not substituted. Current FDA Orange Book lists the exact product as discontinued. The actual discontinuation date is not established and is kept null; approval and observation dates are not substituted.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
No patent facts are recorded for this product.

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-11 · CURRENT_SNAPSHOT_NO_RECORD · Historical coverage: NOT_COMPLETE

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
062391 / 001FINAL_APPROVAL · FINAL_APPROVED1982-09-30—MUTUAL PHARMACEUTICAL CO INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
062269 / 002FINAL_APPROVAL · FINAL_APPROVED1982-11-08—EPIC PHARMA LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
062421 / 001FINAL_APPROVAL · FINAL_APPROVED1983-02-02—ACTAVIS LABORATORIES FL INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
062432 / 001FINAL_APPROVAL · FINAL_APPROVED1983-02-15—MYLAN PHARMACEUTICALS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
062392 / 002FINAL_APPROVAL · FINAL_APPROVED1983-03-31—WATSON LABORATORIES INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
062462 / 001FINAL_APPROVAL · FINAL_APPROVED1983-05-11—HEATHER DRUG CO INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
062505 / 001FINAL_APPROVAL · FINAL_APPROVED1984-09-11—CHARTWELL SCHEDULED LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
062494 / 001FINAL_APPROVAL · FINAL_APPROVED1985-02-20—SUPERPHARM CORPNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
062581 / 001FINAL_APPROVAL · FINAL_APPROVED1985-03-15—TEVA PHARMACEUTICALS USA INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
062593 / 001FINAL_APPROVAL · FINAL_APPROVED1985-08-28—WARNER CHILCOTT DIV WARNER LAMBERT CONEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
062538 / 001FINAL_APPROVAL · FINAL_APPROVED1986-04-07—STRIDES PHARMA INTERNATIONAL AGNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
062677 / 001FINAL_APPROVAL · FINAL_APPROVED1986-07-10—SUN PHARMACEUTICAL INDUSTRIES INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
062764 / 001FINAL_APPROVAL · FINAL_APPROVED1988-09-02—INTERPHARM INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
065095 / 001FINAL_APPROVAL · FINAL_APPROVED2003-07-02—HIKMA INTERNATIONAL PHARMACEUTICALS LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
207558 / 001FINAL_APPROVAL · FINAL_APPROVED2017-09-06—NOVEL LABORATORIES INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
207773 / 001FINAL_APPROVAL · FINAL_APPROVED2017-10-30—ZYDUS LIFESCIENCES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
209969 / 001FINAL_APPROVAL · FINAL_APPROVED2018-11-09—AVET LIFESCIENCES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211343 / 001FINAL_APPROVAL · FINAL_APPROVED2019-10-09—CHANGZHOU PHARMACEUTICAL FACTORYNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
210664 / 001FINAL_APPROVAL · FINAL_APPROVED2020-03-16—ACELLA PHARMACEUTICALS LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
210536 / 001FINAL_APPROVAL · FINAL_APPROVED2020-05-14—ALEMBIC PHARMACEUTICALS LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
213475 / 001FINAL_APPROVAL · FINAL_APPROVED2021-03-10—ORYZA PHARMACEUTICALS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
212487 / 001FINAL_APPROVAL · FINAL_APPROVED2022-03-30—ARTHUR GROUP LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
216599 / 001FINAL_APPROVAL · FINAL_APPROVED2022-10-24—AMNEAL EU LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
209560 / 001FINAL_APPROVAL · FINAL_APPROVED2024-04-15—PHARMOBEDIENT CONSULTING LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211418 / 001FINAL_APPROVAL · FINAL_APPROVED2025-11-19—MACLEODS PHARMACEUTICALS LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 25 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
062391 / 001MUTUAL PHARMACEUTICAL CO INCFINAL_APPROVAL · FINAL_APPROVED1982-09-30 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
062269 / 002EPIC PHARMA LLCFINAL_APPROVAL · FINAL_APPROVED1982-11-08 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
062421 / 001ACTAVIS LABORATORIES FL INCFINAL_APPROVAL · FINAL_APPROVED1983-02-02 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
062432 / 001MYLAN PHARMACEUTICALS INCFINAL_APPROVAL · FINAL_APPROVED1983-02-15 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
062392 / 002WATSON LABORATORIES INCFINAL_APPROVAL · FINAL_APPROVED1983-03-31 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
062462 / 001HEATHER DRUG CO INCFINAL_APPROVAL · FINAL_APPROVED1983-05-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
062505 / 001CHARTWELL SCHEDULED LLCFINAL_APPROVAL · FINAL_APPROVED1984-09-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
062494 / 001SUPERPHARM CORPFINAL_APPROVAL · FINAL_APPROVED1985-02-20 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
062581 / 001TEVA PHARMACEUTICALS USA INCFINAL_APPROVAL · FINAL_APPROVED1985-03-15 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
062593 / 001WARNER CHILCOTT DIV WARNER LAMBERT COFINAL_APPROVAL · FINAL_APPROVED1985-08-28 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
062538 / 001STRIDES PHARMA INTERNATIONAL AGFINAL_APPROVAL · FINAL_APPROVED1986-04-07 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
062677 / 001SUN PHARMACEUTICAL INDUSTRIES INCFINAL_APPROVAL · FINAL_APPROVED1986-07-10 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
062764 / 001INTERPHARM INCFINAL_APPROVAL · FINAL_APPROVED1988-09-02 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
065095 / 001HIKMA INTERNATIONAL PHARMACEUTICALS LLCFINAL_APPROVAL · FINAL_APPROVED2003-07-02 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
207558 / 001NOVEL LABORATORIES INCFINAL_APPROVAL · FINAL_APPROVED2017-09-06 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
207773 / 001ZYDUS LIFESCIENCES LTDFINAL_APPROVAL · FINAL_APPROVED2017-10-30 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
209969 / 001AVET LIFESCIENCES LTDFINAL_APPROVAL · FINAL_APPROVED2018-11-09 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211343 / 001CHANGZHOU PHARMACEUTICAL FACTORYFINAL_APPROVAL · FINAL_APPROVED2019-10-09 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
210664 / 001ACELLA PHARMACEUTICALS LLCFINAL_APPROVAL · FINAL_APPROVED2020-03-16 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
210536 / 001ALEMBIC PHARMACEUTICALS LTDFINAL_APPROVAL · FINAL_APPROVED2020-05-14 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
213475 / 001ORYZA PHARMACEUTICALS INCFINAL_APPROVAL · FINAL_APPROVED2021-03-10 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
212487 / 001ARTHUR GROUP LLCFINAL_APPROVAL · FINAL_APPROVED2022-03-30 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
216599 / 001AMNEAL EU LTDFINAL_APPROVAL · FINAL_APPROVED2022-10-24 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
209560 / 001PHARMOBEDIENT CONSULTING LLCFINAL_APPROVAL · FINAL_APPROVED2024-04-15 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211418 / 001MACLEODS PHARMACEUTICALS LTDFINAL_APPROVAL · FINAL_APPROVED2025-11-19 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
Decision evidence (1)
TypeDateRoleBasisSource
REGULATORY_STATUS—TERMINAL_STATUSCurrent FDA Orange Book lists the exact product as discontinued. The actual discontinuation date is not established and is kept null; approval and observation dates are not substituted. Current FDA Orange Book lists the exact product as discontinued. The actual discontinuation date is not established and is kept null; approval and observation dates are not substituted.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.